Metadate CD Dosage
Generic name: methylphenidate hydrochloride
Dosage form: capsule, extended release
This dosage information does not include all the information needed to use Metadate CD safely and effectively. See full prescribing information for Metadate CD.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
METADATE CD is administered once daily in the morning, before breakfast.
METADATE CD may be swallowed whole with the aid of liquids, or alternatively, the capsule may be opened and the capsule contents sprinkled onto a small amount (tablespoon) of applesauce and given immediately, and not stored for future use. Drinking some fluids, e.g. water, should follow the intake of the sprinkles with applesauce. The capsules and the capsule contents must not be crushed or chewed (see PRECAUTIONS: Information for Patients). Patients should be advised to avoid alcohol while taking Metadate CD.
Dosage should be individualized according to the needs and responses of the patient.
The recommended starting dose of METADATE CD is 20 mg once daily. Dosage may be adjusted in weekly 10-20 mg increments to a maximum of 60 mg/day taken once daily in the morning, depending upon tolerability and degree of efficacy observed. Daily dosage above 60 mg is not recommended.
There is no body of evidence available from controlled trials to indicate how long the patient with ADHD should be treated with METADATE CD. It is generally agreed, however, that pharmacological treatment of ADHD may be needed for extended periods. Nevertheless, the physician who elects to use METADATE CD for extended periods in patients with ADHD should periodically re-evaluate the long-term usefulness of the drug for the individual patient with trials off medication to assess the patient's functioning without pharmacotherapy. Improvement may be sustained when the drug is either temporarily or permanently discontinued.
Dose Reduction And Discontinuation
If paradoxical aggravation of symptoms or other adverse events occur, the dosage should be reduced, or, if necessary, the drug should be discontinued.
If improvement is not observed after appropriate dosage adjustment over a one-month period, the drug should be discontinued.
- Metadate CD Side Effects
- Metadate CD Drug Interactions
- Concerta (methylphenidate hydrochloride) tablet, extended release dosage information
- Concerta (methylphenidate) consumer information
- Daytrana (methylphenidate) patch dosage information
- Daytrana (methylphenidate) consumer information
- Metadate ER (methylphenidate hydrochloride) tablet, extended release dosage information
- Methylin (methylphenidate hydrochloride) tablet dosage information
- Methylphenidate dosage information
- Methylphenidate consumer information
- Quillivant XR (methylphenidate hydrochloride) oral powder, for suspension dosage information
- Quillivant XR (methylphenidate) consumer information
- Ritalin (methylphenidate hydrochloride) tablet and tablet, extended release dosage information
- Ritalin (methylphenidate) consumer information
- Ritalin LA (methylphenidate hydrochloride) capsule, extended release dosage information